Signed Into Law
Signed June 20, 2025Effective 2025-09-01
SB1330

Regular Session

Relating to billing and reimbursement for certain medical equipment, devices, and supplies provided to Medicare enrollees; creating a criminal offense.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who SB1330 Affects

Regulatory Priority: critical

Significant regulatory changes (effective 2025-09-01). Review with your legal and compliance teams to understand implications.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about SB1330

Q

What does Texas SB1330 do?

SB1330 imposes a hard billing cap on nonparticipating suppliers of durable medical equipment (DME), orthotics, and prosthetics, limiting charges to 115% of the Medicare-approved amount. Exceeding this cap without a compliant, pre-signed waiver is now a Class B misdemeanor and constitutes a violation of the Deceptive Trade Practices Act (DTPA), exposing your business to treble damages.

Q

Who authored SB1330?

SB1330 was authored by Texas Senator Kelly Hancock during the Regular Session.

Q

When was SB1330 signed into law?

SB1330 was signed into law by Governor Greg Abbott on June 20, 2025.

Q

Which agencies enforce SB1330?

SB1330 is enforced by County/District Attorneys (Criminal prosecution authorized in Travis County or local venue), Private Civil Litigants (via DTPA) and Texas Attorney General (Consumer Protection/DTPA).

Q

How significant are the changes in SB1330?

The regulatory priority for SB1330 is rated as "critical". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of SB1330?

The cost impact of SB1330 is estimated as "medium". This may vary based on industry and implementation requirements.

Q

What topics does SB1330 address?

SB1330 addresses topics including crimes, crimes--miscellaneous, health care providers, insurance and insurance--life, health & accident.

Q

What are the key dates for SB1330?

Key dates for SB1330: Effective date is 2025-09-01. Consult with legal counsel regarding applicability.

Q

What are the penalties under SB1330?

SB1330 establishes the following penalties: criminal penalty of $500 to $1,000 fine for Intentional violation of billing caps (charging >115% of Medicare rate without compliant waiver) by a nonparticipating supplier. Misdemeanor offense.; civil penalty of Damages under DTPA (potential treble damages + attorney fees) for Violating the billing cap or notice requirements constitutes a false, misleading, or deceptive act under Business & Commerce Code Section 17.46.. Consult with legal counsel for specific applicability to your situation.

Q

Which Texas businesses are affected by SB1330?

SB1330 primarily affects healthcare providers and medical facilities, insurance companies and financial institutions, Texas businesses and commercial enterprises. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026